Page last updated: 2024-08-24

telmisartan and Kidney Diseases

telmisartan has been researched along with Kidney Diseases in 46 studies

Research

Studies (46)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	19 (41.30)	29.6817
2010's	25 (54.35)	24.3611
2020's	2 (4.35)	2.80

Authors

Authors	Studies
Cao, Y; Chen, X; Chu, C; Delic, D; Frankenreiter, S; Gaballa, MMS; Hasan, AA; Hocher, B; Klein, T; Krämer, BK; Luo, T; Stadermann, K; Xiong, Y; Xue, Y; Yin, L; Zeng, S	1
Abdel-Daim, MM; Ahmed, OS; Hassanein, EHM; Mohamed, WR; Sayed, AM	1
Bednarski, R; Donderski, R; Heleniak, Z; Lizakowski, S; Manitius, J; Przybylska, M; Renke, M; Rutkowski, B; Rutkowski, P; Sulikowska, B; Tylicki, L	1
Clase, C; Dagenais, GR; de Zeeuw, D; Gao, P; Heerspink, HJ; Lonn, E; Mann, JF; Sleight, P; Teo, KT; Yusuf, S	1
Sharma, K; Sweiss, N	1
Chen, JA; Gill, AJ; Gross, S; Jarolimek, W; Pollock, CA; Saad, S; Schilter, H; Wong, M; Wong, MG; Zhang, J	1
Asanuma, E; Asanuma, K; Asao, R; Jeong, KH; Kodama, F; Lydia, A; Takagi, M; Tomino, Y	1
Cai, J; Cheng, S; Gao, L; Li, H; Li, M; Liu, P; Song, Y; Tian, G; Wang, Y; Yang, S; Yin, Y; Zhang, H	1
Barzilay, J; Clase, CM; Gao, P; Mann, JF; Schmieder, RE; Smyth, A; Teo, KK; Tobe, S; Yusuf, S	1
Inoue, T; Kawagoe, Y; Koide, H; Nakamura, T; Node, K; Suzuki, T; Ueda, Y	1
Knap, N; Larczynski, W; Neuwelt, A; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L; Wozniak, M	1
Schindler, C	1
Weder, AB	1
Aleksandrowicz, E; Larczyński, W; Lysiak-Szydlowska, W; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L	2
Avezum, A; Cardona-Munoz, E; Dagenais, GR; Diaz, R; Dyal, L; Fodor, G; Maillon, JM; Mann, JF; McQueen, MJ; Pogue, J; Probstfield, JL; Rydén, L; Schmieder, RE; Schumacher, H; Teo, KK; Wang, X; Yu, CM; Yusuf, S	1
Duan, SB; Liu, FY; Peng, YM; Wang, P; Wang, YH; Xu, XQ; Zou, Q	1
Mann, JF; Teo, KK; Tobe, S; Yusuf, S	1
Abutaleb, N	1
Weber, MA	1
Hoogwerf, BJ	1
Al-Melhim, WN; Al-Sultan, AI; Fouad, AA; Qureshi, HA; Yacoubi, MT	1
Gao, B; Li, M; Xia, W; Zheng, F	1
Aizawa, Y; Arozal, W; Kodama, M; Ma, M; Sukumaran, V; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K	1
Gu, XF; Liu, AJ; Liu, W; Ma, XJ; Song, SW; Su, DF; Su, FY; Wang, W; Zhang, H	1
Imig, JD; Khan, AH	1
Fouad, AA; Jresat, I	1
Brown, L; Sernia, C	1
Jennings, G; Liu, GL; Mancia, G; Redon, J; Ryden, L; Schmieder, R; Schumacher, H; Sleight, P; Teo, K; Verdecchia, P; Yusoff, K; Yusuf, S	1
Chalmers, J	1
Cagnoni, F; Cavalleri, C; Destro, M; Dognini, GP; Galimberti, V; Galli, E; Taietti, C	1
Balakumar, P; Bishnoi, HK; Mahadevan, N	1
Ahmad, SJ; Akhtar, M; Najmi, AK; Pillai, KK; Rashikh, A	1
Arumugam, S; Harima, M; Kawachi, H; Lakshmanan, AP; Sari, FR; Soetikno, V; Suzuki, K; Watanabe, K	1
Ishikawa, M; Ishimitsu, T; Kobayashi, N; Onoda, S; Sugiyama, F	1
Smith, DH	1
Terra, SG	1
Weber, M	1
Kira, S; Kobayashi, M; Maeshima, Y; Makino, H; Masuoka, N; Sugiyama, H; Sunami, R; Wang, DH; Yamasaki, Y	1
Aranda, FJ; Aranda, P; Frutos, MA; López de Novales, E; López, V; Ruilope, LM; Segura, J	1
Barnett, A	1
Bianchetti, MG; Fossali, E; Ghiglia, S; Limoni, C; Meier, CM; Salice, P; Simonetti, GD	1
Remuzzi, A; Remuzzi, G	1
Balduini, CL; Fiore, CE; Granata, A; Pecci, A	1
Ramahi, TM	1

Reviews

10 review(s) available for telmisartan and Kidney Diseases

Article	Year
The role of inflammation in cadmium nephrotoxicity: NF-κB comes into view. Life sciences, 2022, Nov-01, Volume: 308 Topics: Acetylcysteine; Cadmium; Cytochalasin D; Cytokines; Humans; Inflammation; Kidney Diseases; NF-kappa B; Polysaccharides; Sildenafil Citrate; Telmisartan	2022
Adiponectin effects on the kidney. Best practice & research. Clinical endocrinology & metabolism, 2014, Volume: 28, Issue:1 Topics: Adiponectin; Albuminuria; Amlodipine; AMP-Activated Protein Kinases; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Humans; Kidney; Kidney Diseases; Mice; Obesity; Oxidative Stress; Perindopril; Renal Insufficiency, Chronic; Telmisartan	2014
Telmisartan in high-risk cardiovascular patients. The American journal of cardiology, 2010, Jan-04, Volume: 105, Issue:1 Suppl Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus; Humans; Kidney Diseases; Ramipril; Risk Factors; Telmisartan	2010
Renin-angiotensin system blockade and cardiovascular and renal protection. The American journal of cardiology, 2010, Jan-04, Volume: 105, Issue:1 Suppl Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus; Drug Therapy, Combination; Humans; Kidney Diseases; Ramipril; Telmisartan	2010
Telmisartan: just an antihypertensive agent? A literature review. Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:17 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atrial Fibrillation; Benzimidazoles; Benzoates; Costs and Cost Analysis; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Renin-Angiotensin System; Telmisartan	2011
Telmisartan in the management of diabetic nephropathy: a contemporary view. Current diabetes reviews, 2012, Volume: 8, Issue:3 Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diabetes Mellitus; Diabetic Nephropathies; Disease Progression; Female; Humans; Hypertension; Kidney Diseases; Male; Telmisartan; Treatment Outcome	2012
Treatment of hypertension with an angiotensin II-receptor antagonist compared with an angiotensin-converting enzyme inhibitor: a review of clinical studies of telmisartan and enalapril. Clinical therapeutics, 2002, Volume: 24, Issue:10 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Clinical Trials as Topic; Enalapril; Humans; Hypertension; Kidney Diseases; Renin-Angiotensin System; Telmisartan	2002
The telmisartan programme of research tO show Telmisartan End-organ proteCTION (PROTECTION) programme. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 2003, Volume: 21, Issue:6 Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Hypertension; Kidney Diseases; Telmisartan	2003
Potential protective effects of telmisartan on renal function deterioration. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2006, Volume: 7, Issue:4 Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Humans; Kidney Diseases; Metabolic Syndrome; Telmisartan	2006
Expanded role for ARBs in cardiovascular and renal disease? Recent observations have far-reaching implications. Postgraduate medicine, 2001, Volume: 109, Issue:4 Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biological Availability; Biphenyl Compounds; Cardiovascular Diseases; Humans; Imidazoles; Irbesartan; Kidney Diseases; Losartan; Metabolic Clearance Rate; Patient Selection; Renin-Angiotensin System; Telmisartan; Tetrazoles; Thiophenes; Treatment Outcome; Valine; Valsartan	2001

Trials

12 trial(s) available for telmisartan and Kidney Diseases

Article	Year
Safety of enhanced renin-angiotensin-aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease. Polskie Archiwum Medycyny Wewnetrznej, 2013, Volume: 123, Issue:5 Topics: Adult; Amides; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fumarates; Humans; Kidney Diseases; Male; Middle Aged; Patient Safety; Renin-Angiotensin System; Severity of Illness Index; Telmisartan; Treatment Outcome	2013
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial. European journal of preventive cardiology, 2014, Volume: 21, Issue:3 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Drug Therapy, Combination; Female; Heart Failure; Hospitalization; Humans; Hyperkalemia; Hypertension; Hypokalemia; Kidney; Kidney Diseases; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Nonlinear Dynamics; Odds Ratio; Potassium; Proportional Hazards Models; Ramipril; Renal Dialysis; Renin-Angiotensin System; Risk Assessment; Risk Factors; Stroke; Telmisartan; Time Factors; Treatment Outcome	2014
Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes. Kidney international, 2017, Volume: 91, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Disease Progression; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Odds Ratio; Ramipril; Renin-Angiotensin System; Risk Factors; Telmisartan; Time Factors; Treatment Outcome	2017
Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency. Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:5 Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cholesterol; Chronic Disease; Creatinine; Female; Humans; Hypertension; Interleukin-6; Kidney Diseases; Male; Matrix Metalloproteinase 9; Middle Aged; Renal Insufficiency; Telmisartan; Triglycerides	2008
Spironolactone attenuates oxidative stress in patients with chronic kidney disease. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:5 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Creatinine; Cross-Over Studies; Dinoprost; Diuretics; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Spironolactone; Telmisartan	2008
Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study. Scandinavian journal of urology and nephrology, 2008, Volume: 42, Issue:4 Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cilazapril; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrosis; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Peptide Fragments; Procollagen; Proteinuria; Renin; Renin-Angiotensin System; Telmisartan; Young Adult	2008
Effect of telmisartan on renal outcomes: a randomized trial. Annals of internal medicine, 2009, Jul-07, Volume: 151, Issue:1 Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Coronary Artery Disease; Creatinine; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Risk Factors; Telmisartan	2009
Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation, 2011, Oct-18, Volume: 124, Issue:16 Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Guidelines as Topic; Humans; Incidence; Kidney Diseases; Middle Aged; Ramipril; Risk; Stroke; Telmisartan	2011
Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 46, Issue:6 Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Creatinine; Dose-Response Relationship, Drug; Dyslipidemias; Female; Follow-Up Studies; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Renin-Angiotensin System; Telmisartan; Treatment Outcome	2005
Preventing renal complications in type 2 diabetes: results of the diabetics exposed to telmisartan and enalapril trial. Journal of the American Society of Nephrology : JASN, 2006, Volume: 17, Issue:4 Suppl 2 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Creatinine; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Enalapril; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Failure, Chronic; Receptors, Angiotensin; Renin-Angiotensin System; Telmisartan	2006
Palatability of angiotensin II antagonists among nephropathic children. British journal of clinical pharmacology, 2007, Volume: 63, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Child; Child, Preschool; Female; Humans; Irbesartan; Kidney Diseases; Losartan; Male; Patient Compliance; Patient Satisfaction; Smell; Taste; Telmisartan; Tetrazoles; Valine; Valsartan	2007
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2008, Volume: 52, Issue:3 Topics: Acetylglucosaminidase; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Collagen Type III; Cross-Over Studies; Disease Progression; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Potassium; Proteinuria; Renin-Angiotensin System; Spironolactone; Telmisartan	2008

Other Studies

24 other study(ies) available for telmisartan and Kidney Diseases

Article	Year
Antifibrotic effects of low dose SGLT2 Inhibition with empagliflozin in comparison to Ang II receptor blockade with telmisartan in 5/6 nephrectomised rats on high salt diet. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 146 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzhydryl Compounds; Dose-Response Relationship, Drug; Fibrosis; Glucosides; Glycosuria; Heart Diseases; Iron; Kidney Diseases; Male; Nephrectomy; Rats; Rats, Wistar; Sequence Analysis, RNA; Sodium-Glucose Transporter 2 Inhibitors; Sodium, Dietary; Telmisartan	2022
Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model. American journal of physiology. Renal physiology, 2014, Oct-15, Volume: 307, Issue:8 Topics: Amine Oxidase (Copper-Containing); Animals; Benzimidazoles; Benzoates; Disease Models, Animal; Enzyme Inhibitors; Fibrosis; Kidney; Kidney Diseases; Mice, Inbred C57BL; Semicarbazides; Telmisartan; Ureteral Obstruction	2014
Combination therapy with telmisartan and oxacalcitriol suppresses the progression of murine adriamycin nephropathy. Nephron, 2015, Volume: 129, Issue:2 Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Antibiotics, Antineoplastic; Apoptosis; Benzimidazoles; Benzoates; Calcitriol; Doxorubicin; Drug Therapy, Combination; Female; Glomerulosclerosis, Focal Segmental; Intracellular Signaling Peptides and Proteins; Kidney Diseases; Membrane Proteins; Mice; Mice, Inbred BALB C; Podocytes; Telmisartan	2015
Telmisartan Ameliorates Nephropathy in Metabolic Syndrome by Reducing Leptin Release From Perirenal Adipose Tissue. Hypertension (Dallas, Tex. : 1979), 2016, Volume: 68, Issue:2 Topics: Adipogenesis; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Disease Models, Animal; Intra-Abdominal Fat; Kidney Diseases; Leptin; Male; Metabolic Syndrome; Protective Agents; Rats; Rats, Wistar; Telmisartan	2016
ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET. Therapeutic advances in cardiovascular disease, 2008, Volume: 2, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Benzimidazoles; Benzoates; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Kidney Diseases; Ramipril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan	2008
ONTARGET: How much RAS inhibition is enough? Current hypertension reports, 2009, Volume: 11, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Humans; Kidney Diseases; Ramipril; Renin-Angiotensin System; Telmisartan	2009
Telmisartan did not prevent renal disease in patients without proteinuria. Annals of internal medicine, 2009, Jul-07, Volume: 151, Issue:1 Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Coronary Artery Disease; Creatinine; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Risk Factors; Telmisartan	2009
The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat model. Acta radiologica (Stockholm, Sweden : 1987), 2009, Volume: 50, Issue:7 Topics: Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Benzoates; Caspase 3; Contrast Media; Creatinine; Diatrizoate; In Situ Nick-End Labeling; Iohexol; Kidney Diseases; Osmolar Concentration; Random Allocation; Rats; Rats, Sprague-Dawley; Telmisartan	2009
Is therapy of people with chronic kidney disease ONTARGET? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Kidney Diseases; Ramipril; Telmisartan; Treatment Outcome	2010
ONTARGET should not be over interpreted. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Kidney Diseases; Ramipril; Telmisartan; Treatment Outcome	2010
Nephroprotective effect of telmisartan in rats with ischemia/reperfusion renal injury. Pharmacology, 2010, Volume: 85, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Benzimidazoles; Benzoates; Blood Pressure; Blood Urea Nitrogen; Caspase 3; Catalase; Creatinine; Disease Models, Animal; Glutathione; Homocysteine; Kidney; Kidney Diseases; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Superoxide Dismutase; Telmisartan; Tumor Necrosis Factor-alpha	2010
Impairment of renal function in a patient with IgA deficiency-associated mesangioproliferative glomerulonephritis. Clinical nephrology, 2010, Volume: 73, Issue:4 Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Creatinine; Glomerulonephritis, Membranoproliferative; Humans; IgA Deficiency; Kidney Diseases; Kidney Function Tests; Male; Telmisartan; Treatment Outcome; Young Adult	2010
Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions. Toxicology, 2011, Jan-11, Volume: 279, Issue:1-3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antioxidants; Benzimidazoles; Benzoates; Daunorubicin; Gene Expression Regulation; Kidney; Kidney Diseases; Kidney Function Tests; Male; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Telmisartan	2011
Synergism of telmisartan and amlodipine on blood pressure reduction and cardiorenal protection in hypertensive rats. Journal of cardiovascular pharmacology, 2011, Volume: 57, Issue:3 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Hypertension; Kidney; Kidney Diseases; Kidney Glomerulus; Male; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Telmisartan; Time Factors	2011
Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome. American journal of hypertension, 2011, Volume: 24, Issue:7 Topics: Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Body Weight; Dietary Fats; Disease Models, Animal; Hypertension; Kidney Diseases; Male; Metabolic Syndrome; PPAR gamma; Rats; Rats, Inbred SHR; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan	2011
Protective effect of telmisartan against cadmium-induced nephrotoxicity in mice. Life sciences, 2011, Jul-04, Volume: 89, Issue:1-2 Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzoates; Blood Urea Nitrogen; Cadmium; Catalase; Creatine; Fas Ligand Protein; Gene Expression Regulation; Glutathione; Immunohistochemistry; Kidney; Kidney Diseases; Lipid Peroxidation; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Telmisartan; Tumor Necrosis Factor-alpha	2011
Emerging benefits of AT1 receptor antagonists with pleiotropic anti-inflammatory activity. American journal of hypertension, 2011, Volume: 24, Issue:7 Topics: Animals; Benzimidazoles; Benzoates; Hypertension; Kidney Diseases; Male; Metabolic Syndrome; Telmisartan; Tetrazoles; Valine; Valsartan	2011
Is a blood pressure target of <130/80 mm Hg still appropriate for high-risk patients? Circulation, 2011, Oct-18, Volume: 124, Issue:16 Topics: Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Guidelines as Topic; Humans; Kidney Diseases; Ramipril; Telmisartan	2011
Aliskiren alleviates doxorubicin-induced nephrotoxicity by inhibiting oxidative stress and podocyte injury. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2013, Volume: 14, Issue:1 Topics: Amides; Animals; Antioxidants; Benzimidazoles; Benzoates; Blood Pressure; Body Weight; Creatinine; Doxorubicin; Fumarates; Kidney Diseases; Lipid Peroxidation; Organ Size; Oxidative Stress; Podocytes; Rats; Rats, Wistar; Renin; Serum Albumin; Systole; Telmisartan; Urea	2013
Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway. Molecular nutrition & food research, 2013, Volume: 57, Issue:9 Topics: Animals; Benzimidazoles; Benzoates; Blood Pressure; Blood Urea Nitrogen; Creatinine; Curcumin; Cyclooxygenase 2; Fibronectins; Fibrosis; Heme Oxygenase (Decyclizing); Inflammation; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Kidney; Kidney Diseases; Male; Nephrectomy; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Signal Transduction; Telmisartan; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha	2013
Renoprotective mechanisms of telmisartan on renal injury and inflammation in SHRSP.Z-Leprfa/IzmDmcr rats. Clinical and experimental nephrology, 2013, Volume: 17, Issue:4 Topics: Animals; Benzimidazoles; Benzoates; Cell Cycle Proteins; Desmin; Epithelial-Mesenchymal Transition; Hydralazine; Kidney Diseases; Male; Metabolic Syndrome; Nephritis; Podocytes; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Smad4 Protein; Telmisartan; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha	2013
Cardiology patient page. Angiotensin receptor blockers. Circulation, 2003, Jun-24, Volume: 107, Issue:24 Topics: Acrylates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Diuretics; Dizziness; Drug Combinations; Drug Interactions; Heart Failure; Humans; Hypertension; Imidazoles; Irbesartan; Kidney Diseases; Losartan; Olmesartan Medoxomil; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan	2003
Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:12 Topics: Acatalasia; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Disease Models, Animal; Fibrosis; Immunohistochemistry; In Situ Nick-End Labeling; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Mice; Mice, Inbred C3H; Mice, Mutant Strains; NADPH Oxidases; Oxidative Stress; Telmisartan; Treatment Outcome; Ureteral Obstruction	2005
Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome). Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:8 Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cataract; Female; Hearing Loss, Sensorineural; Humans; Kidney Diseases; Losartan; Male; Molecular Motor Proteins; Mutation; Myosin Heavy Chains; Proteinuria; Ramipril; Renin-Angiotensin System; Syndrome; Telmisartan; Thrombocytopenia	2008